Study search
Go straight to the source
Search PubMed, Europe PMC and ClinicalTrials.gov from one box. Results come from the indexes themselves, newest first, each linked to its original record.
Amiravo's reviewed summary: Setmelanotide research reference →
221 records · showing 25 · open this search in PubMed
- PubMedObesity in Children Aged 2 to 12 Years: A Review.JAMA · 2026 Oct 21
- PubMedHuman genetic evidence challenges NCOA1 as a monogenic obesity gene.Cell reports. Medicine · 2026 Oct 20
- PubMedImpact of setmelanotide on metabolic syndrome risk in patients with proopiomelanocortin or leptin receptor deficiencies.The Journal of clinical endocrinology and metabolism · 2026 Oct 19
- PubMedLetterAcquired hypothalamic obesity as α-MSH deficiency syndrome: a paradigm shift with therapeutic impact.Molecular and cellular pediatrics · 2026 Oct 15
- PubMedLetterCommentSetmelanotide for the Treatment of Acquired Hypothalamic Obesity. Reply.The New England journal of medicine · 2026 Oct 15
- PubMedLetterCommentSetmelanotide for the Treatment of Acquired Hypothalamic Obesity.The New England journal of medicine · 2026 Oct 15
- PubMedLetterCommentSetmelanotide for the Treatment of Acquired Hypothalamic Obesity.The New England journal of medicine · 2026 Oct 15
- PubMedMeasuring Hunger Severity in Rare MC4R Pathway Diseases: Development and Psychometric Evaluation of the Most Hunger Item.Advances in therapy · 2026 Oct 1
- PubMedSetmelanotide alleviates diabetes-associated cognitive impairment by interrupting the binding of ICAM-1 and JIP1 in endothelial cells of the blood-brain barrier.Metabolism: clinical and experimental · 2026 Oct
- PubMedCase ReportsSafety and effectiveness of setmelanotide in young patients with severe obesity due to craniopharyngioma: a real world monocentric experience.Journal of endocrinological investigation · 2026 Oct
- PubMedCase ReportsSequential Liraglutide and Setmelanotide Therapy in Bardet-Biedl Syndrome: Metabolic and Renal Outcomes in a Real-World Case Report and Literature Review.Nephron · 2026 Sep 15
- PubMedReviewRecent Advances in Glucagon-Like Peptide-1 Receptor and Melanocortin-4 Receptor Agonists for the Treatment of Obesity and Type 2 Diabetes.Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme · 2026 Sep
- PubMedCase ReportsEffectiveness and Safety of Setmelanotide in a Patient With a Heterozygous PCSK1 Deficiency.Obesity (Silver Spring, Md.) · 2026 Sep
- PubMedCase ReportsReviewSetmelanotide in Bardet-Biedl Syndrome: A Case Report.Pediatric dermatology · 2026 Sep-Oct
- PubMedCase ReportsSetmelanotide Response Variability in Two Genetically Confirmed Pediatric Kidney Transplant Recipients with Bardet-Biedl Syndrome.International journal of molecular sciences · 2026 Aug 29
- PubMedDiscovery of TL10: A Soluble and Long-Acting MC4R Agonist with Tunable Lipidation for Sustained Pharmacological Activity.Journal of medicinal chemistry · 2026 Aug 27
- PubMedReviewSetmelanotide.2006
- PubMedGoldilocks-Inspired Design of Mid-Size Macrocycles for Selective Targeting of Human Melanocortin Receptors.Journal of medicinal chemistry · 2026 Aug 13
- PubMedReviewHunger, satiety, and eating behavior after craniopharyngioma - narrative review on current management and future therapeutic perspectives.Frontiers in endocrinology · 2026
- PubMedReviewRationale of renewed efforts in developing MC4R modulators to treat metabolic disorders.Acta pharmaceutica Sinica. B · 2026 Aug
- PubMedMelanocortin-4 Receptor Regulation of Endocrine Axes and Clinical Effects of Setmelanotide.The Journal of clinical endocrinology and metabolism · 2026 Aug 1
- PubMedReviewMonogenic and syndromic obesity in children: Clinical recognition, genetics, and precision management.Pediatric investigation · 2026 Aug
- PubMedRisk of Age-Related Ocular Diseases in Non-Diabetic Adults With Obesity Using Glucagon-Like Peptide 1 Receptor Agonists.Diabetes, obesity & metabolism · 2026 Aug
- PubMedSystematic ReviewMeta-AnalysisAdverse event profile of setmelanotide in obesity: an integrated assessment and systematic review using disproportionality analysis, case reports and meta-analysis.Expert opinion on drug safety · 2026 Aug
- PubMedReviewPharmacologic and Non-Pharmacologic Interventions for Hypothalamic Obesity: An Updated Review.Current obesity reports · 2026 Jul 24
Queries go directly from your browser to NCBI, EMBL-EBI and ClinicalTrials.gov; Amiravo does not store them. Study-type labels come from the indexes and can be wrong. A record's presence says nothing about whether a compound works or is safe. PubMed data via NCBI E-utilities; see NCBI policies.